FLT3-ITD Allele Frequency Is an Independent Prognostic Factor for Poor Outcome in FLT3-ITD–Positive AML Patients
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (10) , 676-685
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemiaBlood Advances, 2018
- FLT3 Inhibitors in AML: Are We There Yet?Current Hematologic Malignancy Reports, 2014
- FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?Hematology-American Society Hematology Education Program, 2013
- Medium-sizedFLT3internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohortLeukemia & Lymphoma, 2013
- Patient‐specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemiaEuropean Journal of Haematology, 2012
- Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemiaLeukemia, 2011
- The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemiaBlood, 2008
- The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patientsLeukemia, 2006
- Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemiaBlood, 2006
- Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisBlood, 2002